Procoagulant platelets in HIT

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00030503

Enrollment

Registered

2023-01-19

Start date

2022-09-01

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heparin-induced thrombocytopenia

Interventions

Group 1: This is a clinical pilot study at the University Hospital Tübingen. Blood samples (2 citrated blood tubes of 5ml each) from patients with suspected acute HIT type II will be collected and ana

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inpatients with acute suspicion of HIT type II, minimum age 18 years, consent to participate in the study possible.

Exclusion criteria

Exclusion criteria: Patients with APS

Design outcomes

Primary

Measure	Time frame
-Collection of blood samples from 10 patients according to the subgroups mentioned above -Aquisition of clinical and laboratory data	—

Secondary

Measure	Time frame
no secondary outcome	—

Countries

Germany

Contacts

Public ContactJan Zlamal

Institut für klinische und experimentelle Transfusionsmedizin

jan.zlamal@med.uni-tuebingen.de07071/2981658

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026